// App-Quantinova.ai

1854 : Incidence and Localization of Vascular Events in a Well Characterized Cohort of 477 Patients with Myeloproliferative Neoplasms

Researchers

Presenter

  • Aurelie Chauveau

Principal Investigators

  • Damien Luque Paz

  • Ronan Le Calloch

  • Caroline Buors

  • Lydie Lecucq

  • Dominique Mottier

  • Valerie Ugo

  • Jean-Christophe Ianotto

Medical Centers

  • Faculte de M, UBO Universite de Bretagne occidentale, Brest, France

  • EA-3878 GETBO, Brest, France

  • Centre dInvestigation clinique, INSERM CIC-05-02, CHRU Brest, Brest, France

  • Service dHematologie Clinique, Institut de cancero-Hematologie, CHRU Brest, Brest, France

  • FIM France Intergroup of Myeloproliferative Neoplams, Brest, France

  • Faculte de Medecine et de Sciences de la Sante, Universite de Bretagne Occidentale, brest, France

  • Departement de Medecine Interne et de Pneumologie, CHRU de Brest, Brest, France

  • CHRU de Brest, EA-3878 GETBO, Brest, France

  • FIM France Intergroup of Myeloproliferative Neoplams, Brest, France

  • Service dHematologie Clinique, Institut de cancero-Hematologie, CHRU Brest, Brest, France

  • Laboratoire dHematologie, University Hospital, Brest, France

  • Laboratoire dHematologie, CHU de Brest, Brest, France

  • FIM France Intergroup of Myeloproliferative Neoplams, Brest, France

  • Laboratoire dHematologie, CHU de Brest, Brest, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Myocardial infarction

  • Essential thrombocythemia

  • Transient Ischemic Attack

  • Transient ischemic attack

  • Deep vein thrombosis

  • Mesenteric ischemia

  • Polycythemia vera

  • Venous thrombosis

  • Ischemic stroke

  • Myelofibrosis

  • Coronary Artery Disease

  • Stroke

Biomarkers

  • MPL proto-oncogene, thrombopoietin receptor

  • Calreticulin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved